Introduction
Cell migration is a complex process integral to normal biological events such as wound healing and inflammatory responses as well as the pathological circumstances of tumor invasion and metastasis. The motile nature of all cell types depends upon the actions of many different molecular components [1] . Central to this process are the signaling and cytoskeletal responses elicited by the interactions of integrins with the extracellular matrix (ECM). The adhesive complexes formed from integrin ligation and activation regulate intracellular signaling events that dictate the cytoskeletal reorganization necessary for cell movement [2] . Several signaling pathways have been shown to be important for cell movement and specific pathways may have crucial roles depending on the extracellular environment [2] [3] [4] [5] . In addition, tumors associated with an invasive and migratory phenotype may favor a certain integrin repertoire [6] [7] [8] , displaying a pivotal role of specific integrin/ECM interactions that favor tumor metastasis.
It is well established that the ECM can induce integrin dependent cell spreading and migration by activation of specific signaling programs that regulate focal adhesion and cytoskeletal dynamics [1, 2] . Interestingly, specific integrin/ECM pairs have been shown to differentially modulate the activities of these programs [5, 9] suggesting that integrin and ECM composition will dictate the signaling response and phenotype. Laminin-5 dependent cell spreading and migratory activities, for example, has been linked to the activities of focal adhesion kinase (FAK), phosphoinositide 3-OH kinase (PI3-K), p21-activated kinase, and the mitogen-activated protein kinase pathway [5, 10, 11] . Inhibition of these pathways using small molecules can ultimately block a migratory phenotype. However, given the multitude of components in these pathways and their redundancy in function, targeted dysregulation of integin/ligand activity may prove to be a more potent method to inhibit motility.
Integrins are evolutionarily conserved heterodimeric cell surface molecules. To date there are 18 distinct α and 8 distinct β subunits that pair in a restrictive manner to give about 24 different integrins that have individual ligand binding specificities [12] . The primary ligands for integrins are proteins of the ECM that consist of type I and IV collagens, fibronectin, laminins, heparin sulfate proteoglycan, and other noncollagenous glycoproteins [13] . The integrins α6β1, α6β4, and α3β1 are laminin receptors, [14, 15] and these integrin pairs are associated with the progression of many epithelial tumors [16] [17] [18] . In particular, the α6 subunit is continually expressed during prostate cancer progression and found in micrometastases [8, 16, 19] . Previous studies have shown that biologically active peptides developed from defined regions within laminin chains can have profound effects on biological events including cell migration and metastasis [20] [21] [22] [23] [24] [25] [26] [27] . These findings prompted us to develop α6-binding cell adhesion peptides.
Our previous work [28, 29] has identified human tumor cell adhesion peptides by using a "one-bead one-compound" combinatorial screening method [30]. Peptides were selected that were capable of binding prostate carcinoma cells expressing the α6 integrin. We characterized two D-amino acid peptides, HYD1 (kikmviswkg) and RZ3 (kmviywkag), as cell adhesion peptides based on their ability to both support tumor cell adhesion themselves and inhibit tumor cell adhesion to immobilized ECM proteins [29] . These peptides do not show homology to any known binding sequences for integrins. In the present study, we examine the effect of these peptides on laminin-5 dependent haptotaxis. HYD1 causes dramatic cytoskeletal reorganization in prostate tumor cells adhered to laminin-5, resulting in a loss of cell migration. HYD1 interacts with both α6 and α3 integrin complexes and induces signaling through focal adhesion kinase In Vivo Actin Distribution Assay-The distribution of globular actin and filamentous actin was analyzed using an F-actin/G-actin in vivo assay kit (Cytoskeleton Inc., Denver CO). Briefly, after peptide treatment, cells were lysed in a cell lysis and F-actin stabilization buffer and homogenized using 27 gauge needles. In order to isolate cellular filamentous actin, cell lysates were centrifuged at 100,000 g for 60 minutes at 37 o C and the supernatants (G-actin) were immediately separated from the pellets (F-actin). The pellets were resuspended in the same volume of dH 2 O as the supernatants and were incubated on ice for 60 minutes. Cytochalasin D (2µM) was added to the resuspended pellets to promote dissociation of filamentous-actin in the pellets into actin monomers. The pellet was then further fractioned to insoluble and soluble forms by centrifugation at 14,000 rpm for 1 minute. The insoluble portion containing the cell membrane was solubilized in RIPA buffer. Equal amounts (2µg of protein for each sample) of each fraction were subjected to SDS-PAGE and analyzed by Western Blot with an anti-actin antibody provided in the kit.
Results

HYD1 blocks laminin-5 dependent migration and invasion. Effect of the peptides, HYD1
and RZ3, on laminin-5 mediated cell migration and invasion was investigated. Video microscopy was used to measure random haptotaxis and a modified Boyden chamber assay was inhibition at a concentration of 250µg/ml (Figure 2A) . The scrambled variant, HYDS, was inactive. The HYD1 peptide was able to inhibit invasion to the same extent as other known inhibitors of invasion such as the Rho-kinase inhibitor, Y-27632 [34] , as well as integrinfunction blocking antibodies to α6, α3, and β1 ( Figure 2B ). The composition of the laminin 5 preparation used in these experiments is shown in Figure 2C . Taken together, these data indicate that HYD1 can block random haptotaxis on laminin-5 and inhibit cellular invasion toward laminin-5.
HYD1 induces actin cytoskeletal remodeling and cortactin mediated actin dynamics at the cell membrane.
A critical component of cell motility dynamics is the regulation of the actin cytoskeleton [35, 36] . Given the immediate loss of motility after HYD1 treatment we investigated the concurrent changes in actin organization. Cells treated for 30 minutes with HYD1 displayed increased filamentous actin and an accumulation of actin at the cell membrane with associated microspikes ( Figure 3A and B-asterisk). This robust change in the cytoskeletal architecture is not seen with treatment of the scrambled peptide, HYDS. Interestingly, although HYD1 generated the formation of stress fibers ( Figure 3B-arrows) , the peptide did not increase Rho activity (data not shown) suggesting Rho-independent signaling events are responsible for the phenotype.
Cortactin is a cortical actin binding protein that localizes at sites of dynamic membrane activity [37] . Given the accumulation of actin and actin microspikes at the cell membrane following HYD1 treatment, we hypothesized that this phenotype may be mediated through cortactin. We show that cortactin is involved in HYD1 induced accumulation of filamentous actin at the cell membrane by its colocalization with actin at the cell membrane in cells treated with HYD1 for 30 minutes ( Figure 3B Inset) . In addition, HYD1 induced an increase in tyrosine phosphorylation of cortactin over time ( Figure 4A ). This is consistent with a concomitant increase in filamentous actin in the cell membrane fraction following treatment with HYD1 for 30 minutes (Figure 4 B, C) . These data show that HYD1 stimulates cytoskeletal reorganization mediated in part by signaling through cortactin.
HYD1 interacts with α6 and α3 integrins and activates integrin-associated signaling.
Given that cell migration on laminin-5 is mediated by α6 and α3 integins [11, [38] [39] [40] [41] , we determined if either peptide interacted with α6 or α3 integrin subunits or the collagen receptor, α2 integrin. To define receptor specificity, each peptide was incubated with membrane preparations from DU-145H prostate carcinoma cells and the resulting precipitate was analyzed for integrin content. HYD1 interacted with complexes containing full-length α6 and α3
integrins but not the α2 integrin ( Figure 5 ). RZ3 interacted with α3 integrin to a greater extent than α6 integrin as judged by the amount of integrin retrieved. HYD1 was superior to RZ3 in retrieving the α6 and α3 subunits. The scrambled derivative, HYDS, does not interact with any tested integrin alpha subunits ( Figure 5 ). Further, since the DU145H cells contain both the α6β1 and α6β4 integrins, we determined if the HYD1 peptide specifically retrieved α6β1 complexes.
Depletion of β1 integrin containing integrins from the lysate removed the opportunity for HYD1
to bind the α6 integrin ( Figure 5 ) indicating that the peptide interacts with the α6β1 heterodimer.
Upon engagement with the ECM, integrins are signal transduction receptors with the capability of activating many intracellular protein kinases and influencing a wide array of cellular processes [12] . One kinase linked to integrin activation and cell motility is focal adhesion kinase (FAK), and phosphorylation of FAK on tyrosine 397 is indicative of FAK activation [42, 43] . Phosphorylation of mitogen activated protein kinase kinase (MEK) on serine 298 is an adhesion dependent phosphorylation regulated by p21-activated kinase (PAK) [44] . Ultimately, signals elicited from integrin interaction with the ECM drive the dynamic adhesive and cytoskeletal remodeling necessary for movement [2] . The anti-migratory activity of HYD1 coupled with its ability to reorganize the cytoskeleton prompted us to analyze the immediate effect on laminin-5 dependent pro-migratory signals. As mentioned previously, cell migration on laminin-5 is coupled to the activity of several kinases including FAK and p21-activated kinase (PAK) [5, 11] . After 5 minutes of treatment, HYD1 increased the amount of activated FAK and elevated phosphorylation of MEK on serine 298, which is mediated by PAK [44] , compared to baseline levels generated by haptotaxis on laminin-5 ( Figure 7A and B Lanes 1 and 2). Both of these signals had the greatest difference above baseline at 15 minutes post-treatment ( Figure 7A and B Lanes 3 and 4). At this time-point, given that PAK phosphorylation of MEK on serine 298 primes the MAPK pathway for activation, [44, 45] we investigated the activation of ERK in response to the peptides. HYD1 induced activation of ERK ( Figure 7C ) and a time course revealed that this response was maximal at 10 min post-treatment and returned to baseline levels after 30 minutes ( Figure 7D ). Taken together these data demonstrate that HYD1 disrupts the normal pro-migratory signaling dynamic on laminin-5 and results in a transient activation of ERK.
Discussion
We have identified a D-amino acid peptide, HYD1 (kikmviswkg), which inhibits tumor cell migration on laminin-5. HYD1 interacts with both α6 and α3-containing integrin complexes but not the α2 integrin. Depletion of the β1 containing integrins from the lysate will remove all α6 integrin that is capable of interacting with HYD1. Since the DU145H cells express both α6β1 and α6β4 integrins, these data indicate that α6β1 integrin and not α6β4 integrin complexes interact with HYD1. Both α6 and α3 containing integrins are receptors for laminin-mediating migration on laminin-5 by use of function-blocking antibodies to α3 [11, 38] , evidence also suggests that α6 integrins play a major regulatory role in motility on laminin-5 [39] [40] [41] . The receptor specificity mediating the direct effects on motility, signaling, and the cytoskeleton will require further investigation.
It is well known that integrin function-blocking antibodies or RGD-based peptiomimetics can inhibit cell invasion by blockage of integrin/ECM interaction. HYD1 is novel in that its activity is not dependent on interrupting integrin/laminin-5 interactions. This suggests that the effects are induced through binding to available integrin complexes on the surface rather than integrin complexes pre-engaged with the ECM. Alternatively, our previous study [29] suggested that HYD1 interaction was independent of the calcium-binding motif. Therefore, the peptide may affect both non-engaged and pre-engaged integrin complexes. The post-ligand occupancy activity of HYD1 is reinforced by the fact that cells remained attached and spread on laminin-5 after peptide treatment. The inhibitory effect of the peptide was reversible by removing the peptide and adding soluble laminin-5. This suggests that the migration-blocking activity is not a lethal event and can be rescued by the normal ligand.
Several peptide sequences that bind α6β1 have been isolated from the laminin α1 chain [22, 47] as well as a peptide from CCN1, [48] a protein that is involved in angiogenesis.
Screening of a phage display library [49] has also isolated α6β1 peptide ligand mimetics. These peptides do not reveal a consensus binding motif and do not overlap with the sequence of HYD1.
In addition, since HYD1 is a D-amino acid peptide it is structurally distinct from other L-amino acid ligand mimetics and therefore not a good candidate for comparative purposes. The peptide sequence was the result of a proposed hybrid D-amino acid containing sequence called HYD1.
The sequence was postulated from the analysis of several adhesion competent D-amino acid sequences that were identified in our previous study. HYD1 does not match any known amino acid sequences within existing proteins because HYD1 is comprised of D-amino acids. The diversity of the ligand sequences for α6β1 may allude to the fact that integrins are involved in a multitude of biological processes and specific ligands could interact with distinct binding sites on integrins to give the appropriate biological response.
Studies have shown that migration rates of cells are dependent on the organization of the actin cytoskeleton and the presence of long, centrally distributed stress fibers correlates with reduced migration rates [9, 10, 50] . HYD1 generates this type of cytoskeletal morphology within 30 minutes, producing a global increase in filamentous actin both at the membrane and throughout the cytoplasm. Cortactin, a regulator of membrane actin dynamics, is also shown to be tyrosine phosphorylated in response to the peptide and colocalized at the cell membrane with filamentous actin. Although the full significance of cortactin phosphorylation has yet to be determined, tyrosine phosphorylation is partially mediated by Src in response to cell matrix interactions [51] . This suggests that the cytoskeletal remodeling events at the cell membrane produced by HYD1 are activated in part by integrin mediated signaling through cortactin.
Interestingly, HYD1 induced cytoskeletal reorganization occurred independent of increased RhoA activity (Data not shown), however, RhoA effectors can be modulated by other signaling pathways such as the MAPK pathway [2, 52] . Therefore, HYD1 may elicit changes in cytoskeletal architecture directly through RhoA effectors rather than increasing RhoA activity.
Alternatively, it has been shown in keratinocytes that ablation of α3β1 created a cytoskeletal reorganization event that resulted in enhanced stress fiber formation [53] . The interaction of HYD1 with α6 and α3 integrins is consistent with the idea that the cytoskeletal effects could be a consequence of inhibiting integrin function independent of modulating actin dynamics through cellular signals.
Laminin-5 dependent motility depends on the activity of multiple cell signaling molecules including FAK, PAK, PI3K, and the MAP-kinase pathway and studies have shown that inhibition of these mediators can reduce migration [10, 11, 33] . It is somewhat surprising then that HYD1 could block migration yet stimulate signaling through these pathways.
However, studies with disintegrins have displayed similar phenomena. For example, it has been
shown that contortrostatin, a snake venom disintegrin that inhibits cell motility, induces the tyrosine phosphorylation of FAK, p130CAS, and activation of ERK2 [54] [55] [56] [57] . Disintegrins have also generated actin cytoskeletal reorganization that was dependent on tyrosine kinase activity [58] . Although HYD1 does not contain a conserved disintegrin domain, the similarity of activity is remarkable.
In summary, we have identified an integrin-targeting peptide, HYD1, that blocks tumor cell migration on laminin-5. Loss of cell migration involved intense cytoskeletal remodeling events mediated in part by cortactin. HYD1 interacts with full-length α6 and α3 integrins and disrupts the pro-migratory signaling dynamic induced from laminin-5 haptotaxis. Therefore HYD1 uncouples the induction of pro-migratory signals with the appropriate cytoskeletal response necessary for motility. The dramatic effect of HYD1 on cell migration and invasion prompts for further study to determine if it can efficiently block invasion and metastasis in vivo.
In addition, we are determining the minimal element for activity in this peptide by deletion analysis. The minimal element of HYD1 may provide insight into novel compounds for drug development. HYD1 is novel because it does not have to compete with the native ligand for activity, suggesting that integrin functions can be regulated independently from adhesion to the extracellular matrix. This study may provide new insights into development of antagonists of specific integrin functions to target cancer metastasis. 
